Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 1871Neoplasms 1257Colorectal Neoplasms 1057Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 802Carcinoma, Hepatocellular 785Lung Neoplasms 769Prostatic Neoplasms 697Pancreatic Neoplasms 577Rectal Neoplasms 449Ovarian Neoplasms 406Colonic Neoplasms 405Neoplasm Metastasis 403Uterine Cervical Neoplasms 400Recurrence 382Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 339Lymphoma 335Head and Neck Neoplasms 330Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 264Urinary Bladder Neoplasms 256Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 216Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 205

Interventions

alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Disease Resistance × Clear all
NCT04708639 2021-02-02

MonAlec

Aarhus University Hospital

Unknown
40 enrolled
Thoracic

Lung Neoplasms, Disease Resistance

NCT03400865 2018-10-16

Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas

Ruijin Hospital

Phase NA Unknown
30 enrolled

Prolactinoma, Disease Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡